Clinical Outcomes of Intravenous Ketamine Treatment for Depression in the VA Health System

Conclusions: While only a minority of patients treated with IV ketamine for depression experienced response or remission, symptom improvements achieved within the first 6 weeks were sustained over at least 6 months with decreasing infusion frequency. Further study is needed to determine optimal infusion frequency and potential for adverse effects with repeated ketamine infusions for depression.PMID:38206011 | DOI:10.4088/JCP.23m14984

Source: Journal of Clinical Psychiatry - January 11, 2024 Category: Psychiatry Authors: Paul N Pfeiffer Jamarie Geller Dara Ganoczy Jennifer Jagusch John Carty Fe Erlita D Festin William S Gilmer Brian Martis Mohini Ranganathan Ilse R Wiechers Avinash Hosanagar Source Type: research